Pharmaceutical Innovation and Mortality in the United States, 1960-2000  

Oleh:

Lichtenberg, Frank

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Social Science & Medicine (www.elsevier.com/locate/sosscimed) vol. 70 no. 7 (Apr. 2010), page 969-971.
Topik: Pharmaceutical Innovation; Life Expectancy

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: SS53 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In 2004, I published a paper (Lichtenberg, 2004a) that used aggregate time-series data to examine the impact of pharmaceutical innovation (new FDA drug approvals) and other variables on the longevity of Americans during the period 1960-2001. I concluded that "the empirical analysis provides support for the hypothesis that both medical innovation (in the form of new drug approvals) and public health expenditure contributed to longevity increase during the period 1960-2001" (Lichtenberg, 2004a, p. 386).

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali